Quantum-Si incorporated

NasdaqGM:QSI Lagerbericht

Marktkapitalisierung: US$187.5m

Quantum-Si Management

Management Kriterienprüfungen 3/4

Quantum-Si CEO ist Jeff Hawkins , ernannt in Oct 2022, hat eine Amtszeit von 3.58 Jahren. Die jährliche Gesamtvergütung beträgt $3.18M , bestehend aus 19.5% Gehalt und 80.5% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.3% der Aktien des Unternehmens, im Wert von $568.21K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.3 Jahre bzw. 3 Jahre.

Wichtige Informationen

Jeff Hawkins

Geschäftsführender

US$3.2m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts19.50%
Amtszeit als Geschäftsführer3.6yrs
Eigentum des Geschäftsführers0.3%
Durchschnittliche Amtszeit des Managements3.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder3yrs

Jüngste Management Updates

Recent updates

Analyseartikel • May 07

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analyseartikel • Dec 13

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha • Oct 27

Quantum-Si: Critical 12 Months Ahead

Summary Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. This hasn't mattered to the stock, as Quantum-Si's share price is being driven more by sentiment and quantum hype than financial performance. The Proteus system could alter the trajectory of the business, but technology risk is high and there is competition. While I am negative on QSI's prospects, shorting the stock is risky given the company's cash balance, potential positive news on Proteus and rebounding biopharma demand. Read the full article on Seeking Alpha
Analyseartikel • Jun 26

We're Hopeful That Quantum-Si (NASDAQ:QSI) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. By way of example, Quantum-Si...
Seeking Alpha • Mar 11

Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet

Summary Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty. The recent surge in Quantum-Si's share price appears to have been driven more by quantum computing hype than the fundamentals of its business. Read the full article on Seeking Alpha
Seeking Alpha • Jan 04

Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell

Summary Similar to data storage solutions provider Quantum Corporation, life sciences company Quantum-Si appears to be have been picked as a quantum computing play solely due to its name. Since listing on Nasdaq in a backdoor IPO almost four years ago, the company has burned almost $350 million in cash and remains way behind its original business plan. However, Quantum-Si has managed to capitalize on the hype by raising additional funds, thus extending its cash runway by more than one year to late 2027. With the company not involved in quantum computing, I would expect momentum traders to leave for assumed greener pastures sooner rather than later. As a result, I am initiating Quantum-Si's common stock with a "Sell" rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 29

Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued

Summary Quantum-Si has seemingly surged as part of the quantum computing trend, but its own operating business is not focused on quantum computing. Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Quantum-Si's balance sheet is healthy for now, but it will likely need more cash by the end of 2026 to commercialize its Platinum platform. Given the unproven business model and potential for a secondary offering, traders would be wise to exit positions now. Read the full article on Seeking Alpha
Seeking Alpha • Dec 16

Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades

Summary Quantum-Si (QSI) has made significant progress in technology and management but missed revenue forecasts for 2024, leading to a revised hold rating. Key partnerships with Nvidia, Planet Innovations, and SkyWater aim to enhance product capabilities, particularly with the upcoming Proteus platform. Despite promising advancements, QSI's commercial traction remains insufficient, delaying profitability and necessitating potential capital raises within two years. The product development roadmap is strong, but substantial revenue growth is crucial for QSI to achieve long-term success and profitability. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

Quantum-Si Is Too Speculative For Me (Technical Analysis)

Summary Quantum-Si has shown bullish price action recently, but I remain skeptical due to its history of bearish trends and potential for a pullback. Short-term momentum is bullish on Quantum-Si stock, but long-term momentum remains bearish, as indicated by the Percentage Price Oscillator (PPO) readings. Volume activity is highly bullish, showing significant institutional interest, yet relative strength remains bearish compared to the S&P 500 index. I recommend waiting for QSI stock to stabilize below the 30-week EMA without making new lows, then reassessing for long-term bullish momentum and institutional buying. Read the full article on Seeking Alpha
Analyseartikel • Nov 06

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analyseartikel • Aug 03

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analyseartikel • Apr 19

Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Seeking Alpha • Feb 05

Quantum-Si: Commercial Lift Imminent

Summary Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product. It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology. If the product is successful, QSI stock is likely significantly undervalued. Read the full article on Seeking Alpha
Analyseartikel • Dec 04

Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analyseartikel • Jun 28

We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha • Oct 04

Jeff Hawkins is the new CEO of Quantum-Si

Quantum-Si (NASDAQ:QSI) appoints veteran life sciences executive Jeff Hawkins as Chief Executive Officer effective October 10, 2022, succeeding Dr. Jonathan Rothberg, Interim Chief Executive Officer, Founder and Executive Chairman. Most recently Jeff Hawkins was President and Chief Executive Officer of Truvian Sciences.
Seeking Alpha • Sep 24

Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform

Novel semiconductor-based next generation protein sequencing platform targeting $64B+ proteomics market in 2024 (15% CAGR). Founded by Dr. Jonathan Rothberg, Professor of Genetics at Yale University (who sequenced the first human genome and is known for inventing high-speed, next-generation DNA sequencing). The company is planning to commercialize its platform next year and could occupy 10% or more of the proteomics market in 5 years, reaching 10x upside in 5-10 years.

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Jeff Hawkins im Vergleich zu den Einnahmen von Quantum-Si verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Mar 31 2026n/an/a

-US$104m

Dec 31 2025US$3mUS$621k

-US$101m

Sep 30 2025n/an/a

-US$117m

Jun 30 2025n/an/a

-US$106m

Mar 31 2025n/an/a

-US$101m

Dec 31 2024US$4mUS$596k

-US$101m

Sep 30 2024n/an/a

-US$90m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$92m

Dec 31 2023US$1mUS$575k

-US$96m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$114m

Mar 31 2023n/an/a

-US$121m

Dec 31 2022US$8mUS$132k

-US$132m

Vergütung im Vergleich zum Markt: JeffDie Gesamtvergütung ($USD3.18M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD1.73M).

Entschädigung vs. Einkommen: JeffDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Jeff Hawkins (47 yo)

3.6yrs
Amtszeit
US$3,183,693
Vergütung

Mr. Jeffrey Alan Hawkins, also known as Jeff, serves as Chief Executive Officer at Quantum-Si incorporated since joining from October 10, 2022 and serves as its Director since October 2022 also serves as i...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Jeffry Keyes
CFO & Treasurer3yrsUS$1.66m0.16%
$ 296.1k
John Vieceli
Chief Product Officer1.8yrsUS$1.46m0.076%
$ 143.3k
Todd Rearick
Chief Technology Officer7.3yrskeine Datenkeine Daten
Christian Lapointe
General Counsel & Corporate Secretary5.5yrsUS$2.07m0.22%
$ 413.2k
Lindsay Thompson
Chief Human Resources Officer1.8yrskeine Datenkeine Daten
3.3yrs
Durchschnittliche Betriebszugehörigkeit
52yo
Durchschnittliches Alter

Erfahrenes Management: QSIDas Führungsteam des Unternehmens gilt als erfahren (3.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Kevin Rakin
Independent Director5.9yrsUS$203.13k0.0094%
$ 17.7k
Brigid Makes
Independent Director4.9yrsUS$208.75k0.0094%
$ 17.7k
Ruth Fattori
Independent Director5.2yrsUS$213.75k0.078%
$ 146.8k
Charles Kummeth
Independent Chairman2yrsUS$245.00k0.39%
$ 736.1k
Scott Mendel
Independent Director3yrsUS$211.25k0.065%
$ 122.1k
Amir Jafri
Independent Director2.7yrsUS$207.50k0.053%
$ 99.8k
Paula Dowdy
Independent Director2.2yrsUS$202.81k0.12%
$ 231.7k
John Kenny
Independent Director3yrsUS$212.50k0.052%
$ 98.4k
Gloria Sheynkman
Chair of the Scientific Advisory Board1.3yrskeine Datenkeine Daten
Benjamin Garcia
Member of the Scientific Advisory Board1.3yrskeine Datenkeine Daten
3.0yrs
Durchschnittliche Betriebszugehörigkeit
60.5yo
Durchschnittliches Alter

Erfahrener Vorstand: QSIDie Vorstandsmitglieder gelten als erfahren (3 Jahre durchschnittliche Amtszeit).

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/20 01:07
Aktienkurs zum Tagesende2026/05/20 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Quantum-Si incorporated wird von 3 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Scott HenryAlliance Global Partners
Kyle MiksonCanaccord Genuity
Swayampakula RamakanthH.C. Wainwright & Co.